Wire Stories
-
674Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (�Takeda�) today announced the completion of its previously-announced sale of a portfolio of select products...
-
604
$756.5 Million Worldwide Isobutanol Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Isobutanol – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The publisher brings years of research...
-
643
Skin Inc, Custom Skin-Tech Leader, Announces�Pre-Series A Funding with Mistletoe�
New Investments Will Accelerate Skin Inc Cloud, E-commerce�and Its Omni-channel Global Expansion SINGAPORE & NEW YORK–(BUSINESS WIRE)–Skin Inc Supplement Bar, the pioneer...
-
697
India Diesel Genset Markets Report 2020-2030: 5 kVA-75 kVA, 76 kVA-375 kVA, 376 kVA-750 kVA, Above 750 kVA – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Diesel Genset Market Research Report: By Power Rating (5 kVA-75 kVA, 76 kVA-375 kVA, 376 kVA-750 kVA, Above 750...
-
648
AM Best Affirms Credit Ratings of Dai-ichi Life Insurance Company, Limited
HONG KONG–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of �aa-� of...
-
614
Pentwater Urges a Halt to Rio Tinto�s Attempt to Obstruct Turquoise Hill�s Financing and Governmental Discussions
NAPLES, Fla.–(BUSINESS WIRE)–Pentwater Capital Management LP (“Pentwater“), the largest minority shareholder of Turquoise Hill Resources Ltd. (“Turquoise Hill” or the “Company“) (TSX:TRQ)...
-
878
New Biomarker Analyses from Patritumab Deruxtecan Phase 1 Study in Patients with EGFR-Mutated NSCLC Presented at WCLC 2020
MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Exploratory biomarker analyses from an ongoing phase 1 study of Daiichi Sankyo Company, Limited�s (hereafter, Daiichi Sankyo)...
-
871
Datopotamab Deruxtecan and ENHERTU� Show Promising Early Clinical Activity in Patients with Advanced Non-Small Cell Lung Cancer
Data at WCLC highlight potential for both antibody drug conjugates as targeted treatments in this setting MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–New...
-
723
Daisuke Iwase, Digital Pioneer in the Insurance Industry Named a Senior Advisor to Omniscience
PALO ALTO, Calif.–(BUSINESS WIRE)–#AI–Daisuke Iwase, Managing Partner at Spiral Capital, has been named senior advisor to Omniscience Corp. of Palo Alto, CA....
-
578
Lufax to Announce Fourth Quarter 2020 Financial Results on February 2, 2021
SHANGHAI, China–(BUSINESS WIRE)–Lufax Holding Ltd (�Lufax� or the �Company�) (NYSE: LU), a leading technology-empowered personal financial services platform in China, today announced...
